QuidelOrtho Corporation (QDEL)
USD 26.72
(1.14%)
USD 26.72
(1.14%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.49 Billion USD | -1.45% |
| 2022 | 2.53 Billion USD | 481.21% |
| 2021 | -664.15 Million USD | -74.12% |
| 2020 | -381.43 Million USD | -740.8% |
| 2019 | 59.52 Million USD | -6.81% |
| 2018 | 63.87 Million USD | -82.32% |
| 2017 | 361.36 Million USD | 1813.34% |
| 2016 | -21.09 Million USD | 51.65% |
| 2015 | -43.62 Million USD | 23.2% |
| 2014 | -56.79 Million USD | -1398.65% |
| 2013 | -3.79 Million USD | 37.51% |
| 2012 | -6.06 Million USD | 54.69% |
| 2011 | -13.38 Million USD | -118.34% |
| 2010 | 72.98 Million USD | 193.04% |
| 2009 | -78.44 Million USD | -54.09% |
| 2008 | -50.9 Million USD | -34.95% |
| 2007 | -37.72 Million USD | -33.84% |
| 2006 | -28.18 Million USD | -39.4% |
| 2005 | -20.22 Million USD | 24.11% |
| 2004 | -26.64 Million USD | -72.67% |
| 2003 | -15.43 Million USD | -299.37% |
| 2002 | 7.74 Million USD | -25.09% |
| 2001 | 10.33 Million USD | -17.32% |
| 2000 | 12.49 Million USD | 0.0% |
| 1998 | -3.6 Million USD | 44.62% |
| 1997 | -6.5 Million USD | 2.99% |
| 1996 | -6.7 Million USD | -419.05% |
| 1995 | 2.1 Million USD | 75.0% |
| 1994 | 1.2 Million USD | -67.57% |
| 1993 | 3.7 Million USD | 164.29% |
| 1992 | 1.4 Million USD | 16.67% |
| 1991 | 1.2 Million USD | 148.0% |
| 1990 | -2.5 Million USD | -933.33% |
| 1989 | 300 Thousand USD | -86.96% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 2.66 Billion USD | 5.11% |
| 2024 Q1 | 2.53 Billion USD | 1.56% |
| 2023 Q4 | 2.49 Billion USD | 0.04% |
| 2023 Q2 | 2.51 Billion USD | 4.22% |
| 2023 Q1 | 2.41 Billion USD | -4.55% |
| 2023 FY | 2.49 Billion USD | -1.45% |
| 2023 Q3 | 2.49 Billion USD | -0.96% |
| 2022 Q4 | 2.53 Billion USD | -4.09% |
| 2022 FY | 2.53 Billion USD | 481.21% |
| 2022 Q2 | 2.53 Billion USD | 323.89% |
| 2022 Q1 | -1.13 Billion USD | -70.16% |
| 2022 Q3 | 2.63 Billion USD | 4.33% |
| 2021 FY | -664.15 Million USD | -74.12% |
| 2021 Q4 | -664.15 Million USD | -52.46% |
| 2021 Q1 | -834.86 Million USD | -118.87% |
| 2021 Q2 | -588.9 Million USD | 29.46% |
| 2021 Q3 | -435.61 Million USD | 26.03% |
| 2020 Q2 | 64.07 Million USD | 2949.79% |
| 2020 Q4 | -381.43 Million USD | -1079.35% |
| 2020 FY | -381.43 Million USD | -740.8% |
| 2020 Q1 | 2.1 Million USD | -96.47% |
| 2020 Q3 | 38.94 Million USD | -39.22% |
| 2019 Q3 | 78.34 Million USD | -12.88% |
| 2019 FY | 59.52 Million USD | -6.81% |
| 2019 Q2 | 89.92 Million USD | -25.27% |
| 2019 Q1 | 120.33 Million USD | 88.4% |
| 2019 Q4 | 59.52 Million USD | -24.02% |
| 2018 FY | 63.87 Million USD | -82.32% |
| 2018 Q1 | 125.06 Million USD | -65.39% |
| 2018 Q2 | 95.7 Million USD | -23.47% |
| 2018 Q3 | 98.37 Million USD | 2.79% |
| 2018 Q4 | 63.87 Million USD | -35.08% |
| 2017 FY | 361.36 Million USD | 1813.34% |
| 2017 Q4 | 361.36 Million USD | 1861.19% |
| 2017 Q1 | -47.73 Million USD | -126.32% |
| 2017 Q2 | -23.93 Million USD | 49.86% |
| 2017 Q3 | -20.51 Million USD | 14.27% |
| 2016 Q1 | -8.66 Million USD | 80.15% |
| 2016 FY | -21.09 Million USD | 51.65% |
| 2016 Q4 | -21.09 Million USD | -240.56% |
| 2016 Q3 | -6.19 Million USD | 35.44% |
| 2016 Q2 | -9.59 Million USD | -10.76% |
| 2015 FY | -43.62 Million USD | 23.2% |
| 2015 Q4 | -43.62 Million USD | -15.79% |
| 2015 Q2 | -64.11 Million USD | 27.65% |
| 2015 Q1 | -88.61 Million USD | -56.01% |
| 2015 Q3 | -37.67 Million USD | 41.24% |
| 2014 Q1 | -20.24 Million USD | -434.14% |
| 2014 Q2 | -12.72 Million USD | 37.16% |
| 2014 FY | -56.79 Million USD | -1398.65% |
| 2014 Q3 | -18.17 Million USD | -42.84% |
| 2014 Q4 | -56.79 Million USD | -212.58% |
| 2013 Q1 | -40.04 Million USD | -560.21% |
| 2013 FY | -3.79 Million USD | 37.51% |
| 2013 Q4 | -3.79 Million USD | 17.27% |
| 2013 Q3 | -4.58 Million USD | 73.14% |
| 2013 Q2 | -17.05 Million USD | 57.4% |
| 2012 FY | -6.06 Million USD | 54.69% |
| 2012 Q4 | -6.06 Million USD | -623.75% |
| 2012 Q1 | 3.64 Million USD | 127.9% |
| 2012 Q2 | 5.23 Million USD | 43.76% |
| 2012 Q3 | 1.15 Million USD | -77.89% |
| 2011 Q1 | -9 Million USD | -112.29% |
| 2011 Q4 | -13.05 Million USD | -679.46% |
| 2011 FY | -13.38 Million USD | -118.34% |
| 2011 Q3 | -1.67 Million USD | 89.03% |
| 2011 Q2 | -15.27 Million USD | -69.61% |
| 2010 Q3 | 72.95 Million USD | 6.54% |
| 2010 Q4 | 73.26 Million USD | 0.42% |
| 2010 FY | 72.98 Million USD | 193.04% |
| 2010 Q1 | 63.31 Million USD | 176.98% |
| 2010 Q2 | 68.48 Million USD | 8.17% |
| 2009 FY | -78.44 Million USD | -54.09% |
| 2009 Q1 | -49.54 Million USD | 2.68% |
| 2009 Q2 | -42.85 Million USD | 13.51% |
| 2009 Q3 | -53.98 Million USD | -25.98% |
| 2009 Q4 | -82.24 Million USD | -52.33% |
| 2008 Q4 | -50.9 Million USD | 7.15% |
| 2008 FY | -50.9 Million USD | -34.95% |
| 2008 Q2 | -53.73 Million USD | 5.66% |
| 2008 Q3 | -54.82 Million USD | -2.03% |
| 2008 Q1 | -56.96 Million USD | -50.99% |
| 2007 Q2 | -28.78 Million USD | 6.25% |
| 2007 FY | -37.72 Million USD | -33.84% |
| 2007 Q4 | -37.72 Million USD | -38.04% |
| 2007 Q3 | -27.33 Million USD | 5.05% |
| 2007 Q1 | -30.7 Million USD | -8.93% |
| 2006 FY | -28.18 Million USD | -39.4% |
| 2006 Q1 | -30.87 Million USD | -52.71% |
| 2006 Q3 | -22 Million USD | 27.38% |
| 2006 Q4 | -28.18 Million USD | -28.11% |
| 2006 Q2 | -30.29 Million USD | 1.87% |
| 2005 Q1 | -34.35 Million USD | -28.95% |
| 2005 FY | -20.22 Million USD | 24.11% |
| 2005 Q4 | -20.22 Million USD | -34.0% |
| 2005 Q3 | -15.08 Million USD | 14.7% |
| 2005 Q2 | -17.68 Million USD | 48.52% |
| 2004 Q4 | -26.64 Million USD | -30.66% |
| 2004 Q3 | -20.39 Million USD | 19.48% |
| 2004 Q2 | -25.32 Million USD | 12.11% |
| 2004 Q1 | -28.81 Million USD | -86.72% |
| 2004 FY | -26.64 Million USD | -72.67% |
| 2003 Q3 | -5.47 Million USD | -89.84% |
| 2003 Q4 | -15.43 Million USD | -181.84% |
| 2003 FY | -15.43 Million USD | -299.37% |
| 2003 Q1 | -2.83 Million USD | -136.63% |
| 2003 Q2 | -2.88 Million USD | -1.73% |
| 2002 FY | 7.74 Million USD | -25.09% |
| 2002 Q4 | 7.74 Million USD | 31.9% |
| 2002 Q3 | 5.86 Million USD | 42.6% |
| 2002 Q2 | 4.11 Million USD | -43.61% |
| 2002 Q1 | 7.29 Million USD | -29.37% |
| 2001 Q4 | 10.33 Million USD | -6.21% |
| 2001 FY | 10.33 Million USD | -17.32% |
| 2001 Q2 | 13.22 Million USD | 11.79% |
| 2001 Q3 | 11.01 Million USD | -16.73% |
| 2001 Q1 | 11.83 Million USD | -5.31% |
| 2000 FY | 12.49 Million USD | 0.0% |
| 2000 Q1 | 8.27 Million USD | 0.0% |
| 2000 Q4 | 12.49 Million USD | 62.38% |
| 2000 Q2 | 7.28 Million USD | -11.93% |
| 2000 Q3 | 7.69 Million USD | 5.66% |
| 1999 Q3 | 4.1 Million USD | 180.39% |
| 1999 Q2 | -5.1 Million USD | -41.67% |
| 1999 Q1 | -3.6 Million USD | -24.14% |
| 1998 Q3 | -5.5 Million USD | 15.38% |
| 1998 Q4 | -2.9 Million USD | 47.27% |
| 1998 FY | -3.6 Million USD | 44.62% |
| 1998 Q1 | -6.5 Million USD | -20.37% |
| 1998 Q2 | -6.5 Million USD | 0.0% |
| 1997 Q1 | -6.7 Million USD | -3450.0% |
| 1997 Q2 | -5 Million USD | 25.37% |
| 1997 FY | -6.5 Million USD | 2.99% |
| 1997 Q4 | -5.4 Million USD | -50.0% |
| 1997 Q3 | -3.6 Million USD | 28.0% |
| 1996 Q1 | 2.1 Million USD | 0.0% |
| 1996 FY | -6.7 Million USD | -419.05% |
| 1996 Q2 | 1.4 Million USD | -33.33% |
| 1996 Q3 | 1.5 Million USD | 7.14% |
| 1996 Q4 | 200 Thousand USD | -86.67% |
| 1995 Q4 | 2.1 Million USD | 0.0% |
| 1995 Q2 | 2.3 Million USD | 91.67% |
| 1995 Q3 | 2.1 Million USD | -8.7% |
| 1995 FY | 2.1 Million USD | 75.0% |
| 1995 Q1 | 1.2 Million USD | -77.36% |
| 1994 Q2 | 3.7 Million USD | 0.0% |
| 1994 Q4 | 5.3 Million USD | 51.43% |
| 1994 Q1 | 3.7 Million USD | 172.55% |
| 1994 Q3 | 3.5 Million USD | -5.41% |
| 1994 FY | 1.2 Million USD | -67.57% |
| 1993 Q3 | -6.5 Million USD | -983.33% |
| 1993 Q2 | -600 Thousand USD | -142.86% |
| 1993 Q1 | 1.4 Million USD | -30.0% |
| 1993 FY | 3.7 Million USD | 164.29% |
| 1993 Q4 | -5.1 Million USD | 21.54% |
| 1992 Q3 | 1.8 Million USD | 38.46% |
| 1992 FY | 1.4 Million USD | 16.67% |
| 1992 Q1 | 1.2 Million USD | -40.0% |
| 1992 Q2 | 1.3 Million USD | 8.33% |
| 1992 Q4 | 2 Million USD | 11.11% |
| 1991 Q1 | -2.5 Million USD | 0.0% |
| 1991 Q3 | 1.6 Million USD | -46.67% |
| 1991 Q2 | 3 Million USD | 220.0% |
| 1991 Q4 | 2 Million USD | 25.0% |
| 1991 FY | 1.2 Million USD | 148.0% |
| 1990 Q1 | 300 Thousand USD | 0.0% |
| 1990 FY | -2.5 Million USD | -933.33% |
| 1989 FY | 300 Thousand USD | -86.96% |
| 1989 Q1 | 2.3 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -96575.707% |
| AngioDynamics, Inc. | -70.14 Million USD | 3657.355% |
| AtriCure, Inc. | -9.81 Million USD | 25519.723% |
| Avinger, Inc. | 10.12 Million USD | -24556.126% |
| Azenta, Inc. | -618.47 Million USD | 503.445% |
| BioLife Solutions, Inc. | 7.25 Million USD | -34302.316% |
| The Cooper Companies, Inc. | 2.44 Billion USD | -1.911% |
| Daxor Corporation | 755.65 Thousand USD | -330101.85% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 169841.497% |
| Femasys Inc. | -15.01 Million USD | 16717.833% |
| GlucoTrack, Inc. | -4.29 Million USD | 58181.937% |
| Harvard Bioscience, Inc. | 38.49 Million USD | -6382.723% |
| Hologic, Inc. | 374.4 Million USD | -566.453% |
| ICU Medical, Inc. | 1.45 Billion USD | -72.024% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 193.794% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 35557.687% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 48325.744% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 58297.804% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 58297.804% |
| Masimo Corporation | 804 Million USD | -210.348% |
| Microbot Medical Inc. | -2.28 Million USD | 109251.356% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 26103.195% |
| Merit Medical Systems, Inc. | 302.22 Million USD | -725.616% |
| Nephros, Inc. | -2.47 Million USD | 101079.361% |
| NovoCure Limited | 355.42 Million USD | -602.041% |
| NEXGEL, Inc. | 98 Thousand USD | -2546022.449% |
| NEXGEL, Inc. | 98 Thousand USD | -2546022.449% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | -4125.214% |
| OraSure Technologies, Inc. | -276.9 Million USD | 1001.11% |
| Pro-Dex, Inc. | 10.91 Million USD | -22758.19% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 7184.41% |
| Predictive Oncology Inc. | -5.87 Million USD | 42594.302% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -82272.046% |
| Repligen Corporation | -39.51 Million USD | 6413.925% |
| Sanara MedTech Inc. | 6.64 Million USD | -37450.637% |
| STAAR Surgical Company | -147.2 Million USD | 1795.063% |
| Sharps Technology, Inc. | -3.01 Million USD | 82916.999% |
| Utah Medical Products, Inc. | -92.52 Million USD | 2796.756% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | -26.982% |
| Jin Medical International Ltd. | -2.81 Million USD | 88691.973% |